ArticleAnnals of hematology2026

Tisagenlecleucel yields superior patient-reported health-related quality of life compared to autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas.

Ellen Obstfelder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.